GSK sells thrombosis brands to Aspen for $1.1 bn

Singapore: GlaxoSmithKline (GSK) has agreed to sell its thrombosis brands, Arixtra and Fraxiparine, and Notre-Dame de Bo...

October 1, 2013 | Tuesday | News
Cytori, Lorem to commercialize Cytori Cell Therapy

Singapore: US-based Cytori Therapeutics and China-based Lorem Vascular have formed a partnership to commercialize Cytori...

November 5, 2013 | Tuesday | News
Shanghai to host 'MEDTEC China 2014'

Singapore: With the objective to promote high-end medical equipment localization, China is holding MEDTEC China 2014 sum...

July 8, 2014 | Tuesday | News
MMR, UNIS join hands with Chinese government

Singapore: MMRGlobal announced that through its China joint venture, Unis-Tonghe MMR International Health Management Ser...

June 11, 2013 | Tuesday | News
Colorcon opens new lab in China

Singapore: US-based Colorcon, a world leader in offering development, supply and technical support to the pharmaceutical...

July 9, 2015 | Thursday | News
China's Shanghai Pharma group to buy Australian Vitaco pharma

Singapore: Chinese drugmaker Shanghai Pharma and private equity firm Primavera capital recently announced their plans to...

August 8, 2016 | Monday | News
Biobanking has attractive prospects in Asia

Asia is becoming increasingly important as a market for upcoming biobanks. Within Asia, India, China and Japan have attr...

June 12, 2012 | Tuesday | Opinion
CPhI China to begin from June 21

Singapore: Hosted by the UBM EMEA and CCCMHPIE and co-organised by UBM Sinoexpo, this year's CPhI China will be conducte...

May 10, 2016 | Tuesday | News
China Cord Blood, Cordlife join hands for stem cell therapy services

Singapore: China Cord Blood Corporation (CCBC) and Cordlife Group, a multi-product healthcare company catering to the mo...

July 25, 2014 | Friday | News
China firm Beigene raises $75 mn

Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 millio...

November 18, 2014 | Tuesday | News
Johns Hopkins releases NCD policy briefs

Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...

February 5, 2013 | Tuesday | Analysis
Generon initiates phase I clinical study for F-652 in Australia

Singapore: Generon (Shanghai)has initiated phase I clinical trial for F-652 in Australia. F-652 is a recombinant protein...

September 6, 2012 | Thursday | News
Type 2 diabetes could be next epidemic in India, China

Singapore: Despite modern science's best efforts, the most common type of diabetes, Type 2, is reaching epidemic levels ...

February 7, 2013 | Thursday | Analysis
Challenge No 1: A culture cauldron

The countries in Asia have different languages, cultures and religion. Some of them are even a melting pot of people fro...

May 17, 2012 | Thursday | Analysis
Aus drug delivery technology gets Chinese patent

Singapore: Australian drug delivery technology company Imugene has received key Chinese patent application for the compa...

April 30, 2013 | Tuesday | News
Successful Year With a Redefined Business Model

Singapore:  SINOPHARM Group, China Chairman: Mr Wei YulinRevenue: $31299.8 mnBusiness: R&D, manufacturing, distrib...

June 23, 2015 | Tuesday | Analysis
China's Zai Lab raises $100mn

Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B finan...

January 11, 2016 | Monday | News
China launches nationwide inspection of vaccines

Singapore: Ahead of a huge recent vaccine scandal racket revealing China's vaccine black market in March this year, Chin...

July 27, 2016 | Wednesday | News